Adjuvant capecitabine in biliary tract cancer: a standard option?

被引：27

作者：

Malka, David ^{[1
]}

Edeline, Julien ^{[2
]}

机构：

[1] Univ Paris Saclay, Gustave Roussy, Dept Canc Med, Villejuif, France

[2] Ctr Eugene Marquis, Dept Med Oncol, Rennes, France

来源：

LANCET ONCOLOGY | 2019年 / 20卷 / 05期

关键词：

GEMCITABINE; CHEMOTHERAPY; TRIAL;

D O I：

10.1016/S1470-2045(19)30022-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：606 / 608

页数：4

共 10 条

[1] Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer
Ebata, T.
Hirano, S.
Konishi, M.
Uesaka, K.
Tsuchiya, Y.
Ohtsuka, M.
Kaneoka, Y.
Yamamoto, M.
Ambo, Y.
Shimizu, Y.
Ozawa, F.
Fukutomi, A.
Ando, M.
Nimura, Y.
Nagino, M.
[J]. BRITISH JOURNAL OF SURGERY, 2018, 105 (03) : 192 - 202
[2] Edeline J, 2019, J CLIN ONCOL
[3] Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
Horgan, Anne M.
Amir, Eitan
Walter, Thomas
Knox, Jennifer J.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (16) : 1934 - 1940
[4] A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)
Nakachi, Kohei
Konishi, Masaru
Ikeda, Masafumi
Mizusawa, Junki
Eba, Junko
Okusaka, Takuji
Ishii, Hiroshi
Fukuda, Haruhiko
Furuse, Junji
[J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (04) : 392 - 395
[5] Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma The ESPAC-3 Periampullary Cancer Randomized Trial
Neoptolemos, John P.
Moore, Malcolm J.
Cox, Trevor F.
Valle, Juan W.
Palmer, Daniel H.
McDonald, Alexander C.
Carter, Ross
Tebbutt, Niall C.
Dervenis, Christos
Smith, David
Glimelius, Bengt
Charnley, Richard M.
Lacaine, Francois
Scarfe, Andrew G.
Middleton, Mark R.
Anthoney, Alan
Ghaneh, Paula
Halloran, Christopher M.
Lerch, Markus M.
Olah, Attila
Rawcliffe, Charlotte L.
Verbeke, Caroline S.
Campbell, Fiona
Buechler, Markus W.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (02): : 147 - 156
[6] Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
Primrose, John N.
Fox, Richard P.
Palmer, Daniel H.
Malik, Hassan Z.
Prasad, Raj
Mirza, Darius
Anthony, Alan
Corrie, Pippa
Falk, Stephen
Finch-Jones, Meg
Wasan, Harpreet
Ross, Paul
Wall, Lucy
Wadsley, Jonathan
Evans, Jeff T. R.
Stocken, Deborah
Praseedom, Raaj
Ma, Yuk Ting
Davidson, Brian
Neoptolemos, John P.
Iveson, Tim
Raftery, James
Zhu, Shihua
Cunningham, David
Garden, O. James
Stubbs, Clive
Valle, Juan W.
Bridgewater, John
[J]. LANCET ONCOLOGY, 2019, 20 (05) : 663 - 673
[7] Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial
Stein, Alexander
Arnold, Dirk
Bridgewater, John
Goldstein, David
Jensen, Lars Henrik
Kluempen, Heinz-Josef
Lohse, Ansgar W.
Nashan, Bjoern
Primrose, John
Schrum, Silke
Shannon, Jenny
Vettorazzi, Eik
Wege, Henning
[J]. BMC CANCER, 2015, 15
[8] Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas, 2002, CANCER, V95, P1685, DOI [10.1002/cncr.10831, DOI 10.1002/CNCR.10831]
[9] Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Valle, Juan
Wasan, Harpreet
Palmer, Daniel H.
Cunningham, David
Anthoney, Alan
Maraveyas, Anthony
Madhusudan, Srinivasan
Iveson, Tim
Hughes, Sharon
Pereira, Stephen P.
Roughton, Michael
Bridgewater, John
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (14) : 1273 - 1281
[10] Matching genomic molecular aberrations with molecular targeted agents: Are biliary tract cancers an ideal playground?
Verlingue, Loic
Hollebecque, Antoine
Boige, Valerie
Ducreux, Michel
Malka, David
Ferte, Charles
[J]. EUROPEAN JOURNAL OF CANCER, 2017, 81 : 161 - 173

← 1 →